ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sagent Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19
November 24, 2020Sagent Pharmaceuticals, a Nichi-Iko Group Company, has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the treatment of COVID-19 in high-risk outpatients and has begun enrolling patients. -
Sagent Pharmaceuticals launches phase 2 trial to evaluate Camostat Mesilate for Covid-19 treatment
November 17, 2020Sagent Pharmaceuticals announced that it has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the treatment of Covid-19 in high-risk outpatients and has begun enrolling patients.
Pharma Sources Insight January 2025
